Sage Therapeutics, Inc. (SAGE)
USD 6.39
(-4.05%)
USD 6.39
(-4.05%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -579.84 Million USD | -6.01% |
| 2022 | -546.98 Million USD | -18.68% |
| 2021 | -460.9 Million USD | -177.3% |
| 2020 | 596.22 Million USD | 184.2% |
| 2019 | -708.12 Million USD | -80.08% |
| 2018 | -393.23 Million USD | -43.96% |
| 2017 | -273.15 Million USD | -70.55% |
| 2016 | -160.16 Million USD | -69.22% |
| 2015 | -94.65 Million USD | -179.95% |
| 2014 | -33.81 Million USD | -84.97% |
| 2013 | -18.27 Million USD | -89.79% |
| 2012 | -9.63 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -101.2 Million USD | 9.07% |
| 2024 Q1 | -117.07 Million USD | -178.27% |
| 2024 Q2 | -111.3 Million USD | 4.94% |
| 2023 FY | -579.84 Million USD | -6.01% |
| 2023 Q4 | -42.07 Million USD | 80.14% |
| 2023 Q2 | -170.45 Million USD | -9.64% |
| 2023 Q3 | -211.84 Million USD | -24.28% |
| 2023 Q1 | -155.47 Million USD | -1.02% |
| 2022 Q3 | -141.48 Million USD | -10.18% |
| 2022 Q2 | -128.4 Million USD | -4.23% |
| 2022 FY | -546.98 Million USD | -18.68% |
| 2022 Q1 | -123.19 Million USD | 1.82% |
| 2022 Q4 | -153.9 Million USD | -8.78% |
| 2021 Q2 | -108.02 Million USD | -11.93% |
| 2021 FY | -460.9 Million USD | -177.3% |
| 2021 Q1 | -96.5 Million USD | -109.91% |
| 2021 Q4 | -125.48 Million USD | 4.13% |
| 2021 Q3 | -130.89 Million USD | -21.17% |
| 2020 Q4 | 973.97 Million USD | 1008.92% |
| 2020 Q2 | -138.96 Million USD | -5.58% |
| 2020 Q1 | -131.62 Million USD | 24.63% |
| 2020 FY | 596.22 Million USD | 184.2% |
| 2020 Q3 | -107.15 Million USD | 22.89% |
| 2019 Q1 | -169.85 Million USD | -3.43% |
| 2019 FY | -708.12 Million USD | -80.08% |
| 2019 Q4 | -174.63 Million USD | 6.7% |
| 2019 Q3 | -187.17 Million USD | -6.08% |
| 2019 Q2 | -176.45 Million USD | -3.89% |
| 2018 Q4 | -164.22 Million USD | -27.56% |
| 2018 FY | -393.23 Million USD | -43.96% |
| 2018 Q1 | -78.11 Million USD | -10.89% |
| 2018 Q2 | -22.14 Million USD | 71.65% |
| 2018 Q3 | -128.74 Million USD | -481.32% |
| 2017 Q2 | -70.85 Million USD | -23.27% |
| 2017 FY | -273.15 Million USD | -70.55% |
| 2017 Q4 | -70.44 Million USD | 5.28% |
| 2017 Q3 | -74.37 Million USD | -4.97% |
| 2017 Q1 | -57.48 Million USD | -1.95% |
| 2016 Q2 | -35 Million USD | -13.97% |
| 2016 Q1 | -30.71 Million USD | -7.35% |
| 2016 Q3 | -38.06 Million USD | -8.74% |
| 2016 FY | -160.16 Million USD | -69.22% |
| 2016 Q4 | -56.37 Million USD | -48.12% |
| 2015 Q1 | -16.89 Million USD | -36.7% |
| 2015 Q2 | -25.05 Million USD | -48.3% |
| 2015 Q4 | -28.61 Million USD | -18.81% |
| 2015 Q3 | -24.08 Million USD | 3.9% |
| 2015 FY | -94.65 Million USD | -179.95% |
| 2014 Q2 | -6.18 Million USD | -6.87% |
| 2014 Q3 | -9.47 Million USD | -53.04% |
| 2014 Q4 | -12.36 Million USD | -30.53% |
| 2014 FY | -33.81 Million USD | -84.97% |
| 2014 Q1 | -5.79 Million USD | -1.31% |
| 2013 FY | -18.27 Million USD | -89.79% |
| 2013 Q4 | -5.71 Million USD | -26.47% |
| 2013 Q1 | -3.38 Million USD | 0.0% |
| 2013 Q2 | -4.65 Million USD | -37.36% |
| 2013 Q3 | -4.51 Million USD | 2.92% |
| 2012 FY | -9.63 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | -46.25 Million USD | -1153.565% |
| Jaguar Health, Inc. | -34.29 Million USD | -1590.966% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -241.206% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -921.598% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -105.493% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 4955.543% |
| ContextLogic Inc. | -328 Million USD | -76.783% |
| MiMedx Group, Inc. | 37.11 Million USD | 1662.262% |
| MEI Pharma, Inc. | 14.54 Million USD | 4087.409% |
| AlloVir, Inc. | -181.33 Million USD | -219.774% |
| Novavax, Inc. | -566.51 Million USD | -2.354% |
| Aptorum Group Limited | -10.52 Million USD | -5410.128% |
| Ardelyx, Inc. | -63.27 Million USD | -816.381% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -182.85% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -20971.434% |
| Vaxcyte, Inc. | -468.04 Million USD | -23.889% |
| Precigen, Inc. | -88.92 Million USD | -552.08% |
| Pharming Group N.V. | -4.87 Million USD | -11783.262% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -246.567% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1848.679% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -2729.774% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -146.118% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -2886.062% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2285.561% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -2285.561% |
| Bicycle Therapeutics plc | -189.94 Million USD | -205.27% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -111.62% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1878.669% |
| Acelyrin, Inc. | -422.06 Million USD | -37.384% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -1431.197% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -1464.453% |
| Senti Biosciences, Inc. | -92.72 Million USD | -525.329% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -405.214% |
| AbCellera Biologics Inc. | -237.2 Million USD | -144.449% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1592.15% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -237.549% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -18238.046% |
| Chimerix, Inc. | -93.06 Million USD | -523.058% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1656.001% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -3206.055% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -1186.344% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -1043.844% |
| Elevation Oncology, Inc. | -45.44 Million USD | -1175.936% |
| Alkermes plc | 414.12 Million USD | 240.019% |
| Fortress Biotech, Inc. | -142.34 Million USD | -307.363% |
| Fortress Biotech, Inc. | -142.34 Million USD | -307.363% |
| Agenus Inc. | -159.54 Million USD | -263.43% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -493.536% |
| Dyadic International, Inc. | -8.22 Million USD | -6945.776% |
| ImmuCell Corporation | -5.74 Million USD | -9987.702% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -48545.05% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -331.342% |
| Lantern Pharma Inc. | -17.87 Million USD | -3143.444% |
| Immix Biopharma, Inc. | -16.14 Million USD | -3492.373% |
| Incyte Corporation | 620.52 Million USD | 193.445% |
| IO Biotech, Inc. | -91.44 Million USD | -534.11% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -694.542% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -2786.287% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -991.452% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -349.537% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -6720.95% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -591.004% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -52.393% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | -14.978% |
| NextCure, Inc. | -67.63 Million USD | -757.296% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -5389.435% |
| Onconetix, Inc. | -36.03 Million USD | -1509.145% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -1290.058% |
| Opthea Limited | -191.84 Million USD | -202.252% |
| PDS Biotechnology Corporation | -43.04 Million USD | -1247.069% |
| PureTech Health plc | -146.19 Million USD | -296.616% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -605.447% |
| Seer, Inc. | -103.46 Million USD | -460.441% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -4496617.317% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -2233.96% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -14609.334% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1881.848% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -752.769% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -1217.539% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -317.065% |
| ChromaDex Corporation | -5.59 Million USD | -10256.296% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -8306.045% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -399.616% |
| CRISPR Therapeutics AG | -222.53 Million USD | -160.562% |
| Precision BioSciences, Inc. | -43.73 Million USD | -1225.793% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -204.365% |
| Innoviva, Inc. | 176.7 Million USD | 428.138% |
| Summit Therapeutics Inc. | -89.73 Million USD | -546.172% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -781.779% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -706.096% |
| ESSA Pharma Inc. | -32.13 Million USD | -1704.466% |
| GlycoMimetics, Inc. | -39.27 Million USD | -1376.371% |
| GT Biopharma, Inc. | -13.57 Million USD | -4171.133% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -164.504% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 767.936% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -1025.789% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -5734.873% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -123.312% |
| Aptose Biosciences Inc. | -52.35 Million USD | -1007.512% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -3920.928% |
| Soligenix, Inc. | -7.69 Million USD | -7432.522% |
| Century Therapeutics, Inc. | -146.54 Million USD | -295.677% |
| Kura Oncology, Inc. | -165.8 Million USD | -249.72% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -520.438% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -6870.177% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -23265.566% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -8842.767% |
| Autolus Therapeutics plc | -195.02 Million USD | -197.316% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -584.939% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -687.175% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -2643.549% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -155.401% |
| GRI Bio, Inc. | -11.38 Million USD | -4992.202% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -12740.691% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -341.982% |
| IGM Biosciences, Inc. | -263.46 Million USD | -120.089% |
| INmune Bio, Inc. | -29.74 Million USD | -1849.662% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -424.205% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1422.9% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3528.737% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -3576.719% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -849.047% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -439.284% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -110.086% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -185.36% |
| Verastem, Inc. | -92.08 Million USD | -529.696% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -1130.188% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -214.887% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -389.82% |
| Histogen Inc. | -10.64 Million USD | -5348.173% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -3647.741% |
| Surrozen, Inc. | -45.78 Million USD | -1166.599% |
| Organovo Holdings, Inc. | -15.08 Million USD | -3743.623% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -11291.397% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -878.129% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -1030.442% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -2193.706% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -7496.763% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -238.533% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -1096.849% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -641.447% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -3709.589% |
| Apollomics, Inc. | -54.83 Million USD | -957.463% |
| Amarin Corporation plc | -67.58 Million USD | -757.917% |
| Mesoblast Limited | -58.79 Million USD | -886.238% |
| Turnstone Biologics Corp. | -59.03 Million USD | -882.262% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -250.298% |
| Synaptogenix, Inc. | -8.31 Million USD | -6874.491% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -3875.381% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -532.395% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -12001.703% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -6465.888% |
| Exelixis, Inc. | 170.88 Million USD | 439.321% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1415.47% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -273.944% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | -12.13% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4811.035% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -7110.343% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1833.281% |
| Gritstone bio, Inc. | -154.63 Million USD | -274.982% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -742.057% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -3286.365% |
| Avid Bioservices, Inc. | -18.67 Million USD | -3004.449% |
| Insmed Incorporated | -709.62 Million USD | 18.288% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -3595.71% |
| MediWound Ltd. | -15.29 Million USD | -3692.341% |
| OmniAb, Inc. | -69.41 Million USD | -735.289% |
| Alector, Inc. | -151.74 Million USD | -282.133% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -436.982% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -1011.93% |
| Zai Lab Limited | -366.57 Million USD | -58.181% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -83.046% |
| Aura Biosciences, Inc. | -84.99 Million USD | -582.248% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -136.192% |
| Immunic, Inc. | -99.22 Million USD | -484.39% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -305.041% |
| Veracyte, Inc. | -85.79 Million USD | -575.854% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -105.755% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3980.57% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -8318.314% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -2985.515% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 200.219% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -2178.117% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1594.379% |
| TG Therapeutics, Inc. | 20.63 Million USD | 2910.299% |
| Galecto, Inc. | -39.9 Million USD | -1353.074% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -1278.165% |
| Fortrea Holdings Inc. | 63.1 Million USD | 1018.937% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -312.866% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1907.926% |
| XBiotech Inc. | -37.51 Million USD | -1445.852% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -742.057% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -763.899% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -437.365% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2158.683% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -988.06% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | -1.869% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -638.736% |
| Vaxxinity, Inc. | -58.28 Million USD | -894.851% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -459.112% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -2505.696% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -570.997% |
| NexImmune, Inc. | -29.19 Million USD | -1886.296% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -10217.356% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -3876.641% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 114.328% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -2177.58% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4849.681% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -356.351% |
| Ainos, Inc. | -13.2 Million USD | -4290.668% |
| Pluri Inc. | -22.15 Million USD | -2516.883% |
| Prothena Corporation plc | -191.03 Million USD | -203.529% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -320.065% |
| Celularity Inc. | -192.28 Million USD | -201.554% |
| Rallybio Corporation | -78.93 Million USD | -634.618% |
| Cue Biopharma, Inc. | -52.14 Million USD | -1011.908% |
| MeiraGTx Holdings plc | -137.06 Million USD | -323.059% |
| Omeros Corporation | -164.53 Million USD | -252.428% |
| Humacyte, Inc. | -100.04 Million USD | -479.577% |
| Immunocore Holdings plc | -59.64 Million USD | -872.102% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -3024.355% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -2268.374% |
| Blueprint Medicines Corporation | -486.27 Million USD | -19.243% |
| CalciMedica, Inc. | -21.87 Million USD | -2550.738% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -676.653% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -341.0% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -238.509% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -77.378% |
| Pulmatrix, Inc. | -14.74 Million USD | -3833.847% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -1522.182% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -552.498% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | -12.528% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -758.387% |
| Cytokinetics, Incorporated | -496.2 Million USD | -16.857% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1584.677% |
| Nutriband Inc. | -4.87 Million USD | -11801.843% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -1229.532% |
| Vor Biopharma Inc. | -126.03 Million USD | -360.066% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 113.669% |
| Evogene Ltd. | -26.39 Million USD | -2097.147% |
| ProKidney Corp. | -151.52 Million USD | -282.683% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -798.503% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -7438.101% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 4.531% |
| CorMedix Inc. | -48.95 Million USD | -1084.386% |
| BioLineRx Ltd. | -49.69 Million USD | -1066.839% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -407.869% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -1423.033% |
| Atai Life Sciences N.V. | -125.47 Million USD | -362.138% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -610.257% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -612.266% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -132.882% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1786.301% |
| MediciNova, Inc. | -9.9 Million USD | -5756.904% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -358.839% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7906.245% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2068.232% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -150.124% |
| Biomea Fusion, Inc. | -126.13 Million USD | -359.705% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -65.955% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1940.572% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -203.444% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -152.159% |
| Absci Corporation | -115.51 Million USD | -401.969% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -2001.892% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -413.745% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -139.447% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -2201.353% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -178.782% |
| Allakos Inc. | -196.05 Million USD | -195.757% |
| Imunon, Inc. | -21.03 Million USD | -2657.19% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -423.973% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 640.49% |
| BioAtla, Inc. | -129.68 Million USD | -347.114% |
| NLS Pharmaceutics AG | -11.8 Million USD | -4811.035% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -3559.97% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -76.925% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -1288.594% |
| XOMA Corporation | -41.84 Million USD | -1285.607% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -450.993% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -377.262% |
| aTyr Pharma, Inc. | -54.91 Million USD | -955.826% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -563.238% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -235.425% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -127.883% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -2601.244% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -6960.347% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3350.25% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -6557030.305% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 271.769% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -8774.304% |
| UroGen Pharma Ltd. | -65.53 Million USD | -784.779% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -549.487% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -7883.589% |
| Orgenesis Inc. | -53.63 Million USD | -981.082% |
| Entera Bio Ltd. | -8.89 Million USD | -6421.752% |
| GH Research PLC | -41.22 Million USD | -1306.649% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -2155.52% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -598.167% |
| Xencor, Inc. | -138.63 Million USD | -318.244% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -11149.193% |
| Replimune Group, Inc. | -234.77 Million USD | -146.983% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -2598.086% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -4056.028% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -8774.304% |
| Portage Biotech Inc. | -18.25 Million USD | -3076.733% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -7906.245% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -452.442% |
| OncoCyte Corporation | -25.13 Million USD | -2206.847% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -5029.202% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4961.062% |
| Purple Biotech Ltd. | 22.27 Million USD | 2703.606% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -7618.97% |
| scPharmaceuticals Inc. | -55.39 Million USD | -946.734% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -2968.359% |
| HilleVax, Inc. | -133.34 Million USD | -334.849% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -4712.424% |
| Tharimmune, Inc. | -9.45 Million USD | -6032.581% |
| Genprex, Inc. | -31.07 Million USD | -1765.932% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -208.112% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1748.007% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -75697.255% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -10545.449% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3681544.066% |
| Savara Inc. | -60 Million USD | -866.302% |
| Curis, Inc. | -48.33 Million USD | -1099.721% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1780.192% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -11014.01% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -7868.242% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -2027.886% |
| BeiGene, Ltd. | -1.2 Billion USD | 51.989% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -2808.071% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | -19.02% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -519.153% |
| Erasca, Inc. | -141.52 Million USD | -309.715% |
| bluebird bio, Inc. | -244.26 Million USD | -137.388% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -12708.755% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 398.213% |
| DBV Technologies S.A. | -76.43 Million USD | -658.647% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -12708.755% |
| Moderna, Inc. | -4.23 Billion USD | 86.321% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1260.86% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -9017.123% |
| Molecular Templates, Inc. | -10.46 Million USD | -5440.311% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -762.396% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -53.911% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -304.609% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -1015.244% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -275.205% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -178.599% |
| MacroGenics, Inc. | -168.24 Million USD | -244.648% |
| RenovoRx, Inc. | -11.39 Million USD | -4988.18% |
| Adicet Bio, Inc. | -152.03 Million USD | -281.384% |
| Prime Medicine, Inc. | -191.29 Million USD | -203.122% |
| Aditxt, Inc. | -26.06 Million USD | -2124.847% |
| Adagene Inc. | -23.71 Million USD | -2344.571% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7832.165% |
| Quantum-Si incorporated | -111.17 Million USD | -421.583% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1732.182% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -3877.625% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 575.232% |
| SciSparc Ltd. | -5.77 Million USD | -9944.154% |
| Vericel Corporation | -6.46 Million USD | -8870.436% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -6598.296% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -2408.043% |
| Generation Bio Co. | -138.56 Million USD | -318.473% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -598.361% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -570.656% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -140.5% |
| Invivyd, Inc. | -207.78 Million USD | -179.065% |
| Relay Therapeutics, Inc. | -373 Million USD | -55.455% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -6082.745% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 2799.358% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -5536.716% |
| 2seventy bio, Inc. | -216.7 Million USD | -167.578% |
| ADMA Biologics, Inc. | 21.63 Million USD | 2780.515% |
| Clene Inc. | -40.54 Million USD | -1330.313% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -2308.225% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -958.196% |
| GeoVax Labs, Inc. | -26.74 Million USD | -2068.232% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -65.643% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -1478.593% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 3706.699% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -459.149% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1605.338% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -240.531% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 15.265% |
| Evaxion Biotech A/S | -22.19 Million USD | -2512.285% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -603.854% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -159.877% |
| Trevena, Inc. | -35.28 Million USD | -1543.19% |
| Surrozen, Inc. | -45.78 Million USD | -1166.599% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -625.31% |
| Cingulate Inc. | -22.75 Million USD | -2447.758% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 7839.576% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -1198.16% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -6942.181% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -465.386% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -690.211% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -834.125% |
| Clearmind Medicine Inc. | -8.74 Million USD | -6533.403% |
| Kronos Bio, Inc. | -121.83 Million USD | -375.949% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -660.997% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -19669.927% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -475.093% |
| Statera Biopharma, Inc. | -98.34 Million USD | -489.614% |
| ImmunityBio, Inc. | -362.25 Million USD | -60.069% |
| Korro Bio, Inc. | -84.53 Million USD | -585.936% |
| Kineta, Inc. | -15.72 Million USD | -3587.903% |
| BioVie Inc. | -32.17 Million USD | -1701.916% |
| Codexis, Inc. | -68.06 Million USD | -751.855% |
| Celularity Inc. | -192.28 Million USD | -201.554% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -160.48% |
| Celcuity Inc. | -66.23 Million USD | -775.504% |
| Virax Biolabs Group Limited | -6.49 Million USD | -8825.597% |
| Cibus, Inc. | -318.88 Million USD | -81.838% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -1248.486% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1613.299% |
| IN8bio, Inc. | -30.33 Million USD | -1811.359% |
| Kodiak Sciences Inc. | -277.32 Million USD | -109.089% |
| Annexon, Inc. | -143.72 Million USD | -303.449% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -368.41% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -796.96% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -2373.336% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -63.924% |
| Eyenovia, Inc. | -25.4 Million USD | -2182.291% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1876.498% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -10325.189% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -632.752% |
| Arcellx, Inc. | -89.88 Million USD | -545.137% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -1176.863% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -322.609% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1763.927% |
| Moolec Science SA | -6.65 Million USD | -8614.548% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -848.427% |
| Geron Corporation | -193.94 Million USD | -198.978% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -1240.598% |
| Royalty Pharma plc | 1.49 Billion USD | 138.86% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -253.218% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -6116.309% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -2548.358% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -239.178% |
| Humacyte, Inc. | -100.04 Million USD | -479.577% |
| Structure Therapeutics Inc. | -102.77 Million USD | -464.193% |
| 89bio, Inc. | -151.2 Million USD | -283.488% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -623.617% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -3887.957% |
| Genelux Corporation | -24.16 Million USD | -2299.541% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1609.309% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -237.612% |
| Notable Labs, Ltd. | -14.65 Million USD | -3856.123% |
| Liquidia Corporation | -73.38 Million USD | -690.157% |
| Mustang Bio, Inc. | -50.72 Million USD | -1043.1% |
| Immunovant, Inc. | -282.7 Million USD | -105.105% |
| Quantum-Si incorporated | -111.17 Million USD | -421.583% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -642.416% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -2626.52% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -468.413% |
| Acasti Pharma Inc. | -11.31 Million USD | -5025.964% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -2429.76% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -3528.737% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -170.889% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -15703.696% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3550.063% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1888.713% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -1301.143% |
| PepGen Inc. | -84.76 Million USD | -584.058% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1856.9% |
| United Therapeutics Corporation | 1.18 Billion USD | 148.937% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2432.423% |
| Solid Biosciences Inc. | -104.31 Million USD | -455.863% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1667.395% |
| Immuneering Corporation | -58.41 Million USD | -892.673% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -11291.397% |
| Silo Pharma, Inc. | -3.85 Million USD | -14939.169% |
| Belite Bio, Inc | -31.66 Million USD | -1731.025% |
| XOMA Corporation | -41.84 Million USD | -1285.607% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -758.781% |
| Bionomics Limited | -17.89 Billion USD | 96.759% |
| Apogee Therapeutics, Inc. | -93 Million USD | -523.473% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1725.137% |
| uniQure N.V. | -282.87 Million USD | -104.987% |
| Cassava Sciences, Inc. | -105.95 Million USD | -447.249% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7832.165% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -347.746% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1684.92% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -6878.771% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1872.611% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -10325.189% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -3980.57% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -6423.22% |
| Altimmune, Inc. | -95.92 Million USD | -504.456% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -688.975% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1725.137% |
| Compugen Ltd. | -12.99 Million USD | -4363.123% |
| Peak Bio, Inc. | -1356.23 USD | -42754373.799% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -1068.956% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2478.253% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -139.307% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1849.334% |
| Zura Bio Limited | -62.63 Million USD | -825.714% |
| PolyPid Ltd. | -22.86 Million USD | -2435.746% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -3462.601% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1849.334% |
| Instil Bio, Inc. | -159.16 Million USD | -264.298% |
| argenx SE | -425.04 Million USD | -36.419% |
| Immunome, Inc. | -109.53 Million USD | -429.397% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -1051.339% |
| Verona Pharma plc | -67.83 Million USD | -754.845% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -2125.054% |
| Shattuck Labs, Inc. | -91.95 Million USD | -530.565% |
| CervoMed Inc. | -7.81 Million USD | -7321.692% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -693.119% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -4252.894% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1103.655% |
| Moolec Science SA | -6.65 Million USD | -8614.548% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -3425.252% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -328.798% |
| AnaptysBio, Inc. | -164.41 Million USD | -252.683% |
| Design Therapeutics, Inc. | -78.19 Million USD | -641.59% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -566.179% |
| NeurAxis, Inc. | -6.66 Million USD | -8600.569% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -1331.761% |
| Lumos Pharma, Inc. | -36.61 Million USD | -1483.681% |
| Achilles Therapeutics plc | -75.25 Million USD | -670.512% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -2125.054% |
| 180 Life Sciences Corp. | -13.47 Million USD | -4202.348% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 11345.423% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -19669.927% |
| Nutriband Inc. | -4.87 Million USD | -11801.843% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -423.424% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -945.734% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -1040.627% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -777.243% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -971.352% |
| Palisade Bio, Inc. | -13.07 Million USD | -4336.488% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -1176.947% |
| Beam Therapeutics Inc. | -176.48 Million USD | -228.554% |
| Neurogene Inc. | -55.58 Million USD | -943.213% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -431.221% |
| AEON Biopharma, Inc. | -48.42 Million USD | -1097.318% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -499.575% |
| Sesen Bio, Inc. | -25.9 Million USD | -2138.022% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -594.189% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -4506.767% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | -25.901% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -700.465% |
| Athira Pharma, Inc. | -125.46 Million USD | -362.156% |
| Vaccinex, Inc. | -22.88 Million USD | -2433.751% |
| HCW Biologics Inc. | -25.71 Million USD | -2154.716% |
| XOMA Corporation | -41.84 Million USD | -1285.607% |
| Nektar Therapeutics | -137.42 Million USD | -321.939% |
| Arvinas, Inc. | -401.5 Million USD | -44.421% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -6557030.305% |
| Merus N.V. | -156.54 Million USD | -270.399% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -478.34% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1574.896% |
| Rezolute, Inc. | -70.42 Million USD | -723.38% |
| Clene Inc. | -40.54 Million USD | -1330.313% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -3440.312% |
| BeyondSpring Inc. | -23.11 Million USD | -2408.648% |
| Synlogic, Inc. | -55.16 Million USD | -951.194% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -3134.14% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -5257.068% |
| Peak Bio, Inc. | -1356.23 USD | -42754373.799% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -1331.62% |
| Krystal Biotech, Inc. | -109.72 Million USD | -428.447% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -347.622% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -69.046% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -12117.757% |
| MannKind Corporation | 8.67 Million USD | 6781.828% |
| Ikena Oncology, Inc. | -75.41 Million USD | -668.857% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -5910.667% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -762.485% |
| Gossamer Bio, Inc. | -183.75 Million USD | -215.549% |
| CohBar, Inc. | -12.38 Million USD | -4580.619% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -1043.145% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -2001.892% |
| Legend Biotech Corporation | -439.48 Million USD | -31.938% |
| Mural Oncology plc | -194.63 Million USD | -197.912% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -763.603% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3491.448% |
| Disc Medicine, Inc. | -91.12 Million USD | -536.323% |
| Champions Oncology, Inc. | -7.35 Million USD | -7782.667% |
| REGENXBIO Inc. | -268.12 Million USD | -116.258% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -5309.954% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -939.976% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -1388.294% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -407.052% |
| Vaxart, Inc. | -83.34 Million USD | -595.705% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -6705.733% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -1254.975% |
| Cellectis S.A. | -106.62 Million USD | -443.816% |
| Longeveron Inc. | -21.02 Million USD | -2657.378% |
| Repare Therapeutics Inc. | -116.22 Million USD | -398.906% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -116.504% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -666.54% |
| Revolution Medicines, Inc. | -487.18 Million USD | -19.02% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -8616.912% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -1219.218% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -677.382% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -732.698% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -5166.088% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 113.461% |
| Denali Therapeutics Inc. | -196.69 Million USD | -194.79% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -6598.296% |
| Veru Inc. | -93.78 Million USD | -518.293% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -2385.529% |
| Cingulate Inc. | -22.75 Million USD | -2447.758% |
| Passage Bio, Inc. | -108.38 Million USD | -434.97% |
| Context Therapeutics Inc. | -25.07 Million USD | -2212.679% |
| Exicure, Inc. | -14.99 Million USD | -3766.691% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -181.393% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -1328.27% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -5867.405% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -214.525% |
| Nuvalent, Inc. | -149.49 Million USD | -287.88% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -6957.121% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -553.491% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -2691.225% |
| OmniAb, Inc. | -69.41 Million USD | -735.289% |
| Anew Medical, Inc. | -1.3 Million USD | -44474.967% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -4440.357% |
| Lipocine Inc. | -17.93 Million USD | -3133.787% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -746.334% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -661.436% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -1422.9% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -1366.969% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -2490.462% |
| Ocugen, Inc. | -65.53 Million USD | -784.847% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -517.741% |
| Q32 Bio Inc. | -92.1 Million USD | -529.573% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -2604.646% |
| Alumis Inc. Common Stock | -158.17 Million USD | -266.589% |
| Equillium, Inc. | -14.52 Million USD | -3892.9% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -829.156% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -7236.751% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2973.659% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -1135.009% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -434.591% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -4744.179% |
| Dominari Holdings Inc. | -21.79 Million USD | -2560.346% |
| Edesa Biotech, Inc. | -9.22 Million USD | -6187.154% |
| vTv Therapeutics Inc. | -25.5 Million USD | -2173.739% |
| Bio-Techne Corporation | 206.68 Million USD | 380.546% |
| Agios Pharmaceuticals, Inc. | -391.48 Million USD | -48.114% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 401.958% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -338.36% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -1410.377% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -283.749% |
| Nkarta, Inc. | -131.65 Million USD | -340.447% |
| BioCardia, Inc. | -11.64 Million USD | -4879.809% |
| Iterum Therapeutics plc | -47.46 Million USD | -1121.558% |